Cancer screening in Israel: Our Best Clinics and Costs 2026

Dr. Ofer Merimsky is the Deputy Director of the Oncology Institute at Sourasky Medical Center. He brings specialized expertise to cancer screening for complex thoracic and skeletal conditions.

• Directs the National Center for bone and soft tissue sarcomas in Israel
• Board-certified oncology specialist trained at the Institut Gustave Roussy in France
• Past President of the Israeli Society for Oncology and Radiotherapy
• Expertise includes screening for lung tumors and gastrointestinal stromal tumors
• Member of international groups like ASCO and the European Society for Medical Oncology

Professor Nadir Arber directs the Integrated Cancer Prevention Center at Sourasky Medical Center. He specializes in screening for early detection of gastrointestinal tumors.

• Authored over 300 scientific papers on cancer prevention and gene therapy
• Identifies esophageal, pancreatic, and colon cancers at early stages
• Member of the American Association for Cancer Research (AACR)
• Trained at the NewYork-Presbyterian Center in the United States
• Treats liver and stomach tumors using gene therapy research findings

Prof. Amos Toren, MD, PhD, MHA, is a pediatric hemato-oncologist and BMT specialist. He served as Director of Pediatric Hemato-Oncology and BMT at Sheba Medical Center.

He is board certified in Pediatrics, Pediatric Hemato-Oncology, and Bone Marrow Transplantation. He holds a PhD in Human Genetics. He was Head of the Hematology Division at Tel Aviv University for two terms. He is a member of ASH, COG, ESPHI, EBMT, and CIBMTR. He also serves on the Ministry of Health Cord Blood Committee.

He led one of Israel’s most advanced pediatric oncology and BMT programs. The program treated children and young adults. His focus includes leukemia and lymphoma, immunodeficiencies, and rare cancers. He specializes in BMT and CAR T-cell therapy.

His translational research covers CAR T cells, cytokine-induced killer cells, pediatric brain tumors, and targeted therapies. He has worked with St. Anna, the NIH, and St. Jude. His publications include studies on pediatric SCT prophylaxis and PARP resistance.

Professor Amit Tirosh heads the Neuroendocrine Tumors Service at Sheba Medical Center. He specializes in screening for rare hereditary syndromes and complex endocrine cancers.

• Trained in endocrine tumor genetics at the National Institutes of Health in the USA
• International expert on von Hippel–Lindau disease and MEN1 syndrome
• Helped write clinical guidelines for managing patients with hereditary tumor syndromes
• Member of the European Neuroendocrine Tumor Society
• Author of 40 peer-reviewed articles in journals like Radiology and Oncology